MedTrace Logo

Study of 3D Scanning for Adolescent Scoliosis

NCT06035952 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2023-09-13

No results posted yet for this study

Summary

The investigators aim to validate three-dimensional topographical scanning technology as a tool for evaluation of scoliosis. Through the incorporation of 3D topographical technology in the measurement of deformity, the investigators hope to validate a novel approach to quantify deformity progression and provide an accessible alternative to traditional radiographic workup.

Conditions

  • Scoliosis

Interventions

DIAGNOSTIC_TEST

3D topographical scan

Subjects will undergo a quick, radiation-free, no contact 3D scan using a smartphone.

Sponsors & Collaborators

  • NSite Medical

    lead INDUSTRY

Principal Investigators

  • Kali Tileston, MD · Stanford University

Eligibility

Min Age
10 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-08-07
Primary Completion
2023-10-15
Completion
2023-12-15
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06035952 on ClinicalTrials.gov